Skip to main content

Table 2 Baseline characteristics

From: Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study

 

Less than 6 cycles

Exactly 6 cycles

More than 6 cycles

Exactly 6 cycles—no PD

PD before end of treatment (N = 567)

No PD before end of treatment (N = 584)

Total (N =  1151)

PD before end of treatment (N = 80)

No PD before end of treatment (N = 475)

Total (N =  555)

PD before end of treatment (N = 66)

No PD before end of treatment (N = 273)

Total (N =  339)

Treatment

DOX 75 (N = 223)

DOX 50-IFO 5 (N = 80)

DOX 75-IFO 5 (N = 63)

DOX 75-IFO 10 (N = 109)

Total (N = 475)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

Gender

 Male

273 (48.1)

284 (48.6)

557 (48.4)

45 (56.3)

226 (47.6)

271 (48.8)

26 (39.4)

139 (50.9)

165 (48.7)

102 (45.7)

34 (42.5)

30 (47.6)

60 (55.0)

226 (47.6)

 Female

294 (51.9)

299 (51.2)

593 (51.5)

35 (43.8)

248 (52.2)

283 (51.0)

40 (60.6)

134 (49.1)

174 (51.3)

121 (54.3)

45 (56.3)

33 (52.4)

49 (45.0)

248 (52.2)

 Missing

0 (0.0)

1 (0.2)

1 (0.1)

0 (0.0)

1 (0.2)

1 (0.2)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (1.3)

0 (0.0)

0 (0.0)

1 (0.2)

Age

 < 40 years

122 (21.5)

124 (21.2)

246 (21.4)

26 (32.5)

125 (26.3)

151 (27.2)

18 (27.3)

80 (29.3)

98 (28.9)

45 (20.2)

23 (28.8)

26 (41.3)

31 (28.4)

125 (26.3)

 40–50 years

137 (24.2)

122 (20.9)

259 (22.5)

20 (25.0)

115 (24.2)

135 (24.3)

11 (16.7)

64 (23.4)

75 (22.1)

54 (24.2)

15 (18.8)

9 (14.3)

37 (33.9)

115 (24.2)

 50–60 years

164 (28.9)

170 (29.1)

334 (29.0)

19 (23.8)

148 (31.2)

167 (30.1)

13 (19.7)

73 (26.7)

86 (25.4)

77 (34.5)

19 (23.8)

14 (22.2)

38 (34.9)

148 (31.2)

 >  = 60 years

134 (23.6)

156 (26.7)

290 (25.2)

13 (16.3)

85 (17.9)

98 (17.7)

16 (24.2)

49 (17.9)

65 (19.2)

47 (21.1)

21 (26.3)

14 (22.2)

3 (2.8)

85 (17.9)

 Missing

10 (1.8)

12 (2.1)

22 (1.9)

2 (2.5)

2 (0.4)

4 (0.7)

8 (12.1)

7 (2.6)

15 (4.4)

0 (0.0)

2 (2.5)

0 (0.0)

0 (0.0)

2 (0.4)

Performance status

 PS 0

223 (39.3)

265 (45.4)

488 (42.4)

38 (47.5)

274 (57.7)

312 (56.2)

25 (37.9)

127 (46.5)

152 (44.8)

132 (59.2)

39 (48.8)

38 (60.3)

65 (59.6)

274 (57.7)

 PS 1

275 (48.5)

265 (45.4)

540 (46.9)

34 (42.5)

189 (39.8)

223 (40.2)

32 (48.5)

120 (44.0)

152 (44.8)

84 (37.7)

37 (46.3)

24 (38.1)

44 (40.4)

189 (39.8)

 PS 2 + 

67 (11.8)

51 (8.7)

118 (10.3)

8 (10.0)

11 (2.3)

19 (3.4)

9 (13.6)

24 (8.8)

33 (9.7)

7 (3.1)

3 (3.8)

1 (1.6)

0 (0.0)

11 (2.3)

 Missing

2 (0.4)

3 (0.5)

5 (0.4)

0 (0.0)

1 (0.2)

1 (0.2)

0 (0.0)

2 (0.7)

2 (0.6)

0 (0.0)

1 (1.3)

0 (0.0)

0 (0.0)

1 (0.2)